YD Bio (YDESW) Cash & Current Investments (2024 - 2026)

YD Bio (YDESW) has reported Cash & Current Investments for 3 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 466.96% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $2.7 million, a 466.96% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 91.8% from the prior year.
• Cash & Current Investments was $2.7 million for Q2 2026 at YD Bio, down from $6.0 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $6.0 million in Q4 2025 and troughed at $469520.0 in Q2 2025.
• A 3-year average of $3.1 million and a median of $2.9 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 91.8% in 2025 and soared 466.96% in 2026, its largest moves.
• Over 3 years, Cash & Current Investments stood at $3.1 million in 2024, then jumped by 91.8% to $6.0 million in 2025, then slumped by 55.69% to $2.7 million in 2026.
• The last three Cash & Current Investments figures came in at $2.7 million (Q2 2026), $6.0 million (Q4 2025), and $469520.0 (Q2 2025), per Business Quant data.